OverviewSuggest Edit

TELA Bio is a medical technology company focused on designing, developing and marketing tissue reinforcement materials to address the needs in soft tissue reconstruction. The company offers a range of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery.

TypePublic
Founded2012
HQMalvern, US
Websitetelabio.com

Latest Updates

Employees (est.) (Dec 2019)89(+2%)
Revenue (FY, 2019)$15.4 M(+87%)
Share Price (Sept 2020)$15.9
Cybersecurity ratingBMore

Key People/Management at TELA Bio

Antony Koblish

Antony Koblish

Co-founder, President, Chief Executive Officer
E. Skott Greenhalgh

E. Skott Greenhalgh

Chief Technology Officer
Maarten Persenaire

Maarten Persenaire

Co-founder, Chief Medical Officer
Matt Zuga

Matt Zuga

Director
Greg Firestone

Greg Firestone

Vice President, Strategic Customer Relations
Ashley Friedman

Ashley Friedman

Director
Show more

TELA Bio Office Locations

TELA Bio has offices in Malvern and Auckland
Malvern, US (HQ)
1 Great Valley Pkwy #24
Auckland, NZ
2 Kingsford Smith Place, Mangere
Show all (2)

TELA Bio Financials and Metrics

TELA Bio Revenue

TELA Bio's revenue was reported to be $15.45 m in FY, 2019
USD

Revenue (Q2, 2020)

3.5m

Net income (Q2, 2020)

(6.1m)

EBIT (Q2, 2020)

(5.2m)

Market capitalization (22-Sept-2020)

229.3m

Closing stock price (22-Sept-2020)

15.9

Cash (30-Jun-2020)

85.5m

EV

174.4m
TELA Bio's current market capitalization is $229.3 m.
Annual
USDFY, 2017FY, 2018FY, 2019

Revenue

4.2m8.3m15.4m

Revenue growth, %

95%

Cost of goods sold

1.7m5.3m

Gross profit

2.5m2.9m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

1.6m2.1m2.2m3.3m3.3m4.0m3.7m3.5m

Cost of goods sold

1.3m1.7m845.0k1.5m1.4m

Gross profit

208.0k339.0k1.4m1.8m1.9m

Gross profit Margin, %

13%16%62%54%58%
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

11.3m17.3m45.3m

Accounts Receivable

757.0k1.3m2.8m

Prepaid Expenses

429.0k330.0k2.3m

Inventories

1.8m4.3m4.6m
Quarterly
USDQ2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

15.8m10.7m41.4m85.5m

Accounts Receivable

1.9m2.3m2.0m2.6m

Prepaid Expenses

384.0k365.0k1.8m1.5m

Inventories

4.6m4.3m4.8m4.6m
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

(21.3m)(21.1m)(22.4m)

Depreciation and Amortization

761.0k463.0k278.0k

Inventories

(1.8m)

Accounts Payable

(114.0k)(62.0k)(773.0k)
Quarterly
USDQ2, 2018Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(10.9m)(11.2m)(15.9m)(7.2m)(13.3m)

Depreciation and Amortization

309.0k135.0k206.0k56.0k95.0k

Inventories

(1.0m)(617.0k)(750.0k)

Accounts Payable

324.0k(1.3m)(2.5m)(1.3m)(2.1m)
USDFY, 2017

Revenue/Employee

95.5k

Debt/Equity

1.4 x

Debt/Assets

0.3 x

Financial Leverage

4.9 x
Show all financial metrics

TELA Bio Operating Metrics

Jun, 2019

Patients Enrolled

32

Surgeons Collaborated

100
Show all operating metrics

TELA Bio Acquisitions / Subsidiaries

Company NameDateDeal Size
TELA Bio, Limited

TELA Bio Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

TELA Bio Online and Social Media Presence

Embed Graph

TELA Bio News and Updates

TELA Bio Announces Interim Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair

MALVERN, Pa., July 09, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced the results o…

TELA Bio Announces Pricing of Public Offering of Common Stock

MALVERN, Pa., June 25, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced the pricing o…

TELA Bio Announces Fourth Quarter and Full Year 2019 Financial Results

MALVERN, Pa., March 27, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reporte…

TELA Bio to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 27, 2020

MALVERN, Pa., March 11, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced tha…

TELA Bio Announces Appointment of New Chief Commercial Officer

MALVERN, Pa., Jan. 29, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announce…

TELA Bio Announces Third Quarter 2019 Financial Results

MALVERN, Pa., Dec. 18, 2019 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reported…
Show more

TELA Bio Frequently Asked Questions

  • When was TELA Bio founded?

    TELA Bio was founded in 2012.

  • Who are TELA Bio key executives?

    TELA Bio's key executives are Antony Koblish, E. Skott Greenhalgh and Maarten Persenaire.

  • How many employees does TELA Bio have?

    TELA Bio has 89 employees.

  • What is TELA Bio revenue?

    Latest TELA Bio annual revenue is $15.4 m.

  • What is TELA Bio revenue per employee?

    Latest TELA Bio revenue per employee is $173.6 k.

  • Who are TELA Bio competitors?

    Competitors of TELA Bio include Alpine, ARTPred and Annaida Technologies.

  • Where is TELA Bio headquarters?

    TELA Bio headquarters is located at 1 Great Valley Pkwy #24, Malvern.

  • Where are TELA Bio offices?

    TELA Bio has offices in Malvern and Auckland.

  • How many offices does TELA Bio have?

    TELA Bio has 2 offices.